All of the EPH/ephrins investigated in Hepatocellular Carcinoma (HCC), with the only exception of ephrin-A5, seem to have a negative impact on carcinogenesis and patients’ clinical outcomes. The gene discussed is EPHA1; the disease is hepatocellular carcinoma.